{"name": "Pharmaxis",
 "permalink": "pharmaxis",
 "crunchbase_url": "http://www.crunchbase.com/company/pharmaxis",
 "homepage_url": "http://www.pharmaxis.com.au",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@pharmaxis.com.au",
 "phone_number": "61-2-9454-7200",
 "description": "Specialist pharmaceutical company",
 "created_at": "Wed Mar 13 02:58:09 UTC 2013",
 "updated_at": "Wed Mar 13 03:09:19 UTC 2013",
 "overview": "\u003Cp\u003EPharmaxis Ltd (ACN 082 811 630) is a specialist pharmaceutical company involved in the research, development and\ncommercialization of therapeutic products for chronic respiratory disorders. Its product Aridol\u00ae forthe assessment of asthma issold in key international markets. Its product Bronchitol\u00ae for cystic fibrosis is recently launched in Europe and Australia and its development pipeline of productsincludes, Bronchitol for bronchiectasis, PXS64 forthe treatment of lung fibrosis, ASM8 for asthma and PXS4728 for fibrotic disease. Pharmaxisislisted on the Australian Securities Exchange (symbol PXS). The company\u2019s head office and manufacturing facilities are located in Sydney. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       46],
      "assets/images/resized/0024/2067/242067v1-max-150x150.jpg"],
     [[250,
       78],
      "assets/images/resized/0024/2067/242067v1-max-250x250.jpg"],
     [[410,
       128],
      "assets/images/resized/0024/2067/242067v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Chief Executive Officer  ",
    "person":
     {"first_name": "Gary",
      "last_name": "Phillips",
      "permalink": "gary-phillips",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0024/2069/242069v1-max-150x150.jpg"],
          [[150,
            150],
           "assets/images/resized/0024/2069/242069v1-max-250x250.jpg"],
          [[150,
            150],
           "assets/images/resized/0024/2069/242069v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Non-Executive Director",
    "person":
     {"first_name": "William",
      "last_name": "L Delaat",
      "permalink": "william-l-delaat",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0024/2070/242070v1-max-150x150.jpg"],
          [[150,
            150],
           "assets/images/resized/0024/2070/242070v1-max-250x250.jpg"],
          [[150,
            150],
           "assets/images/resized/0024/2070/242070v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Locked Bag 5015",
    "address2": "Frenchs Forest",
    "zip_code": "2086",
    "city": "NSW",
    "state_code": null,
    "country_code": "AUS",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        128],
       "assets/images/resized/0024/2068/242068v1-max-150x150.jpg"],
      [[250,
        214],
       "assets/images/resized/0024/2068/242068v1-max-250x250.jpg"],
      [[450,
        386],
       "assets/images/resized/0024/2068/242068v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}